MaaT Pharma SA (EPA:MAAT)
France
· Delayed Price · Currency is EUR 4.160
-0.070 (-1.65%)
At close: Dec 5, 2025
MaaT Pharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | -31.13 | -28.9 | -19.72 | -13.71 | -9.02 | -5.3 | Upgrade
|
| Depreciation & Amortization | 1.59 | 1.55 | 0.79 | 0.37 | 0.29 | 0.13 | Upgrade
|
| Other Amortization | 0.14 | 0.14 | 0.08 | 0.06 | 0.04 | 0.04 | Upgrade
|
| Stock-Based Compensation | 1.64 | 1.53 | 0.87 | 0.65 | 0.79 | 0.02 | Upgrade
|
| Other Operating Activities | 0.41 | 0.27 | -0.31 | 0.08 | 0.19 | 0.04 | Upgrade
|
| Change in Accounts Receivable | -11.22 | -0.95 | 0.35 | -0.32 | -0.39 | - | Upgrade
|
| Change in Inventory | 0.09 | 0.13 | -0.14 | -0.01 | -0.03 | - | Upgrade
|
| Change in Accounts Payable | 4.94 | 2.48 | 1.84 | 2.04 | 1.07 | -0.28 | Upgrade
|
| Change in Other Net Operating Assets | 8.87 | 1.73 | -2.43 | -1.75 | -0.86 | -0.48 | Upgrade
|
| Operating Cash Flow | -24.67 | -22.04 | -18.67 | -12.61 | -7.93 | -5.84 | Upgrade
|
| Capital Expenditures | -0.78 | -0.75 | -1.09 | -0.66 | -0.24 | -0.32 | Upgrade
|
| Investment in Securities | -0.04 | -0.06 | 0.01 | -0.2 | - | -0.18 | Upgrade
|
| Other Investing Activities | 0.33 | 0.4 | 0.64 | 0.05 | - | - | Upgrade
|
| Investing Cash Flow | -0.49 | -0.42 | -0.44 | -0.82 | -0.24 | -0.49 | Upgrade
|
| Long-Term Debt Issued | - | 5.12 | - | 7.48 | 0.46 | 3.52 | Upgrade
|
| Long-Term Debt Repaid | - | -3.58 | -4.19 | -1.93 | -0.95 | -0.58 | Upgrade
|
| Net Debt Issued (Repaid) | -3.53 | 1.54 | -4.19 | 5.55 | -0.49 | 2.94 | Upgrade
|
| Issuance of Common Stock | 12.21 | 17.26 | 12.59 | 0.1 | 32.44 | 17.95 | Upgrade
|
| Repurchase of Common Stock | -0.08 | - | -0.08 | -0.14 | - | - | Upgrade
|
| Other Financing Activities | 0.45 | -0.47 | -0.18 | -0.15 | -0.1 | -0.05 | Upgrade
|
| Financing Cash Flow | 9.05 | 18.33 | 8.14 | 5.36 | 31.56 | 20.84 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | - | 0 | -0 | - | - | Upgrade
|
| Net Cash Flow | -16.11 | -4.13 | -10.97 | -8.06 | 23.39 | 14.5 | Upgrade
|
| Free Cash Flow | -25.45 | -22.79 | -19.76 | -13.27 | -8.17 | -6.16 | Upgrade
|
| Free Cash Flow Margin | -648.96% | -708.77% | -887.03% | -927.76% | -840.23% | - | Upgrade
|
| Free Cash Flow Per Share | -1.75 | -1.75 | -1.74 | -1.34 | -3.37 | -5.97 | Upgrade
|
| Cash Interest Paid | 0.45 | 0.49 | 0.18 | 0.15 | 0.1 | 0.05 | Upgrade
|
| Levered Free Cash Flow | -22.28 | -12.25 | -11.13 | -8.04 | -4.99 | -4.57 | Upgrade
|
| Unlevered Free Cash Flow | -21.59 | -11.71 | -10.88 | -7.92 | -4.92 | -4.55 | Upgrade
|
| Change in Working Capital | 2.68 | 3.38 | -0.38 | -0.05 | -0.21 | -0.76 | Upgrade
|
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.